| Term 
 | Definition 
 
        | -Cancer cells fail to respond to molecular signals from either within or without - due to genetic mutations
 - Reprogram for uncontrolled growth
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | normally protect against effects of malignant changes due to oncogenes |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mutated genes that have become autonomous |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Programmed cell death -Cancer cells evade this, and become immortalized
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Formation of new blood vessels - Cancer cells do this to satisfy increased O2 and nutrient requirement of tumor
 |  | 
        |  | 
        
        | Term 
 
        | Cancer cells and immune system |  | Definition 
 
        | - Cancer cells avoid detection by body's immune system |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cells break loose from site of origin and implant in other tissues |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Activated to reactive intermediates capable of forming adducts with DNA |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -First use of chemical agents to treat cancer from it -WWI
 -Extremely vesicant low boiling liquid that causes severe blistering of the skin
 - two chloroethyl groups each attached to a S atom
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | US ship John Harvey blew up killing a lot of people b/c tons of mustard gas was on it. |  | 
        |  | 
        
        | Term 
 
        | Mechlorethamine (Mustargen, Nitrogen Mustard) |  | Definition 
 
        | First drug for chemo of cancer in 1946 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Acts as an alkylating agent, thru the intermediacy of the highly reactive three membered aziridinium ion |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alkylating Group:  CH2CH2Cl |  | 
        |  | 
        
        | Term 
 
        | Alkylating Agent Mechanism |  | Definition 
 
        | -Disrupt DNA structure and function -Enhanced in cells that undergo mitosis
 |  | 
        |  | 
        
        | Term 
 
        | p53 Tummor suppressor gene |  | Definition 
 
        | -Causes activation of DNA repair enzymes -Controls transition of cell from G1 phase to the S Phase
 -initiates apoptosis
 -mutations may lead to resistance
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | React with and damage DNA |  | 
        |  | 
        
        | Term 
 
        | Cell Cycle non specific drugs |  | Definition 
 
        | Do not target any one phase of the cell cycle. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antidote for Mechlorethamine extravasation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | IV drugs leak out cause problems |  | 
        |  | 
        
        | Term 
 
        | Melphalan and Chlorambucil |  | Definition 
 
        | Have a benzene ring that acts as an electron sink |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | For chronic lymphocytic leukemia   nitrogen mustard alkylating agent |  | 
        |  | 
        
        | Term 
 
        | Melphalan (Phenylalanine mustard, Alkeran) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cyclophosphamide (Cytoxan) |  | Definition 
 
        | -Breast, ovarian, non-Hodgkin's Lymphoma, Burkitt's Lymphoma -Oxidized by Cytochrome P450
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Causes hemorrhagic cystitis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -alkylating agent -Testicular tumors, can cause hemorrhagic cystitis via acrolein formation
 |  | 
        |  | 
        
        | Term 
 
        | Mesna (Sodium 2-mercaptoethane sulfonate) |  | Definition 
 
        | Treats Hemorrhagic cystitis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Treats hemorrhagic cystitis -Acetaminophen Overdose
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Treats hemorrhagic cystitis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Bifunctional Alkylating agent -treats chronic lymphocytic leukemia and Hodgkin's disease
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Interacts with microtubules, causing disassembly - Mitotic inhibitor
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Carmustine (BCNU) and Lomustine (CCNU) -Highly lipophilic, can cross BBB
 -Important to treat brain tumors
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Biodegradable wafer, direct application, and it dissolves following surgery |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Naturally occurring antibiotic for treatment of islet cell carcinoma (insulinoma) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Undergo spontaneous degradation -Can cause interstrand or intrastrand DNA crosslinks
 -Cytotoxicity
 |  | 
        |  | 
        
        | Term 
 
        | Guanine O6alkyl transferase |  | Definition 
 
        | -DNA repair enzyme -Major DNA adducts formed with nitrosourea degradation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibits guanine O6alkyl transferase |  | 
        |  | 
        
        | Term 
 
        | Dacarbazine (5-dimethyltriazinyl-4imidazolecarboxamide; DTIC-Dome) |  | Definition 
 
        | -Combo therapy for Hodgkin's disease and malignant melanoma -must be given IV
 -Penetrates CNS poorly
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Rapid oral absorb -Crosses BBB
 -Standard drug in Tx of Gliomas in combo with radiation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -MSU - Metastatic testicular and ovarian tumors
 -Advanced bladder cancer
 -Renal damage, peripheral neuropathy, ototoxicity, and N/V (more than carboplatinum)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cl atoms of cisplatin are displaced by water, yields a + molecule to react with nucleophiles |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | approved only in advanced ovarian cancer |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | approved for use in combo with fluorouracil and leucovorin for the Tx of colorectal cancer -Cold induced neuropathies (avoid cold temps)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cytoprotective drug -Reduce renal toxicities w/Cisplatin
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | advanced ovarian cancer after failure of front line Tx -activity b/c formaldehyde is released
 |  | 
        |  | 
        
        | Term 
 
        | Triethylenethiophosphoramide (ThioTEPA, Thioplex) |  | Definition 
 
        | 3 aziridine rings -used to control intracavitary effusions secondary to diffuse or localised neoplastic dz of serosal cavities
 -Superficial papillary carcinoma of urinary bladder
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Bifunctional alkylating agent, has a mesylate group at each end -used orally in the Tx of the chronic phase of chronic myelogenous leukemia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Chronic phase of chronic myelogenous leukemia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ABX first isolated from Strep caespitosus -IV use in desseminated adenocarcinoma of the stomach or pancreas
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Hydrazine derivative, first was a MAO-I -Used in combo to Tx Hodgkin's Disease
 |  | 
        |  |